IL1B and Insulin resistance: In particular, hepatic insulin resistance is able to promote liver inflammation through the activation of the innate immune system and production of harmful cytokines [2], including tumor necrosis factor-alpha, interleukin-1beta, interleukin 6, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathways.